| 1 |
19166694 | Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia. | 2009 Feb 1 |
1 |
| 2 |
17668698 | Lipid-modifying and pleiotropic effects of gemfibrozil, simvastatin and pravastatin in patients with dyslipidemia. | 2006 |
1 |
| 3 |
15618549 | Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation. | 2005 Mar |
2 |
| 4 |
11947915 | A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus. | 2002 May |
2 |
| 5 |
11694861 | Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates? | 2001 Nov |
1 |
| 6 |
10910008 | Platelet function in patients with familial hypertriglyceridemia: evidence that platelet reactivity is modulated by apolipoprotein E content of very-low-density lipoprotein particles. | 2000 Jul |
1 |
| 7 |
9507986 | Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil. | 1998 Feb |
3 |
| 8 |
9514936 | No effect of fibrates on synthesis of apolipoprotein(a) in primary cultures of cynomolgus monkey and human hepatocytes: apolipoprotein A-I synthesis increased. | 1998 Mar 17 |
2 |
| 9 |
9678787 | Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia. | 1998 May |
6 |
| 10 |
9298501 | Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity. | 1997 Aug |
1 |
| 11 |
8647932 | Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. | 1996 Jun 1 |
1 |
| 12 |
8696946 | Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2). | 1996 Aug |
5 |
| 13 |
8900208 | Protein-DNA interactions at a drug-responsive element of the human apolipoprotein A-I gene. | 1996 Oct 25 |
7 |
| 14 |
8257455 | Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity. | 1993 Aug |
1 |
| 15 |
1811554 | Effects of gemfibrozil and ketoconazole on human apolipoprotein AI, B and E levels in two hepatoma cell lines, HepG2 and Hep3B. | 1991 Nov |
2 |
| 16 |
1907081 | HDL metabolism in HDL deficiency associated with familial hypertriglyceridemia: effect of treatment with gemfibrozil. | 1991 |
2 |
| 17 |
1992957 | Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results. | 1991 Feb |
1 |
| 18 |
2203245 | Pharmacotherapy of disorders of plasma lipoprotein metabolism. | 1990 Sep 4 |
1 |
| 19 |
3907298 | The Gemfibrozil Study. | 1985 |
1 |
| 20 |
3923042 | Mechanism of action of gemfibrozil on lipoprotein metabolism. | 1985 May |
3 |
| 21 |
7018466 | The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC). | 1981 |
1 |